Corbus Pharmaceuticals Holdings I.../ US21833P3010 /
2024-05-20 10:00:00 PM | Chg. +3.5500 | Volume | Bid10:00:00 AM | Ask10:00:00 AM | High | Low |
---|---|---|---|---|---|---|
48.5500USD | +7.89% | 301,323 Turnover: 11.32 mill. |
47.6300Bid Size: 300 | 55.0000Ask Size: 600 | 49.1800 | 44.5100 |
GlobeNewswire
05-09
Corbus Pharmaceuticals to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
05-07
Corbus Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
04-24
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO Annual Meeting
GlobeNewswire
04-02
Corbus Announces Dosing of First Patient in U.S. Phase 1 Clinical Trial of Its Next Generation Necti...
GlobeNewswire
03-12
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corpo...
GlobeNewswire
03-06
Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
GlobeNewswire
02-06
Corbus Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
GlobeNewswire
02-02
Corbus Pharmaceuticals Announces Closing of $94.5 Million Public Offering of Common Stock including ...
GlobeNewswire
01-26
CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting Antibody Drug Conjugate Demonstrates Encourag...
GlobeNewswire
01-09
Corbus Pharmaceuticals Announces FDA Clearance of IND Application for its anti-αvβ8 monoclonal antib...
GlobeNewswire
2023-12-18
Corbus Pharmaceuticals Announces Abstract Accepted for Presentation at 2024 ASCO GU
GlobeNewswire
2023-11-07
Corbus Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
2023-11-02
Corbus Pharmaceuticals Presents Results of Two Pre-Clinical Studies on its Anti-αVβ8 Monoclonal Anti...
GlobeNewswire
2023-10-17
Corbus Pharmaceuticals Announces Publication of Data for its Novel Cannabinoid Type-1 Receptor Inver...
GlobeNewswire
2023-10-16
Corbus Pharmaceuticals Presents the First Pre-Clinical Characterization of its Next Generation Necti...
GlobeNewswire
2023-10-03
Corbus Pharmaceuticals to Host Virtual ‘Meet the Expert’ Series (Session 2) on CRB-701 on October 10...
GlobeNewswire
2021-08-12
Corbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
GlobeNewswire
2021-06-24
Corbus Pharmaceuticals Announces Topline Results from DETERMINE Phase 3 Study of Lenabasum for Treat...
GlobeNewswire
2021-06-01
Corbus Pharmaceuticals Licenses Two Integrin Targeting mAbs Further Expanding Pipeline into Cancer a...
GlobeNewswire
2021-05-25
Corbus Pharmaceuticals Announces Publication of Two Abstracts at EULAR 2021 Virtual Congress